Budillon G et al. |
D-glucaric acid excretion during chenodeoxycholate therapy for gallstones. |
1978 |
Lancet |
pmid:74626
|
de Wolff FA et al. |
Valproate induces urinary D-glucaric acid excretion. |
1981 |
Lancet |
pmid:6111706
|
Krafft A et al. |
Erythropoietic quality of maternal milk. |
1999 |
Lancet |
pmid:10475225
|
Hu Q et al. |
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. |
2010 |
Lab. Invest. |
pmid:20065947
|
Yoon J et al. |
Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement. |
2010 |
Korean J. Intern. Med. |
pmid:21179286
|
Okada M et al. |
Hypophosphatemia induced by intravenous administration of Saccharated iron oxide. |
1983 |
Klin. Wochenschr. |
pmid:6843038
|
Blaustein DA et al. |
The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. |
2003 |
Kidney Int. Suppl. |
pmid:14531777
|
Keven K et al. |
Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients. |
2005 |
Kidney Int. |
pmid:15954940
|
Agarwal R |
Is i.v. iron really superior in CKD patients not on dialysis? |
2006 |
Kidney Int. |
pmid:16957750
|
Zager RA |
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. |
2005 |
Kidney Int. |
pmid:16164630
|
Agarwal R |
Proinflammatory effects of iron sucrose in chronic kidney disease. |
2006 |
Kidney Int. |
pmid:16609688
|
Deicher R et al. |
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. |
2003 |
Kidney Int. |
pmid:12846772
|
Agarwal R |
Transferrin saturation with intravenous irons: an in vitro study. |
2004 |
Kidney Int. |
pmid:15327409
|
Aronoff GR et al. |
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. |
2004 |
Kidney Int. |
pmid:15327417
|
Zager RA et al. |
Parenteral iron nephrotoxicity: potential mechanisms and consequences. |
2004 |
Kidney Int. |
pmid:15200421
|
Sengoelge G et al. |
Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. |
2004 |
Kidney Int. |
pmid:15200437
|
Zager RA et al. |
Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. |
2016 |
Kidney Int. |
pmid:27165818
|
Agarwal R et al. |
A randomized trial of intravenous and oral iron in chronic kidney disease. |
2015 |
Kidney Int. |
pmid:26083656
|
Vikrant S |
Optimum dosage regimen for iron sucrose. |
2007 |
Kidney Int. |
pmid:17625585
|
Agarwal R et al. |
Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. |
2007 |
Kidney Int. |
pmid:17622274
|
Jaber BL |
Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. |
2008 |
Kidney Int. |
pmid:18235527
|
Lim R et al. |
A permanent tan from iron. |
2008 |
Kidney Int. |
pmid:18340355
|
Auerbach M and Al Talib K |
Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. |
2008 |
Kidney Int. |
pmid:18274543
|
Schaller G et al. |
Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. |
2005 |
Kidney Int. |
pmid:16316358
|
Van Wyck DB et al. |
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. |
2005 |
Kidney Int. |
pmid:16316362
|
Zheng H et al. |
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. |
2006 |
Kidney Int. |
pmid:16395269
|
Almilaji A et al. |
Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. |
2014 |
Kidney Blood Press. Res. |
pmid:25571875
|
Tanaka H et al. |
[A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)]. |
1982 |
Kansenshogaku Zasshi |
pmid:6809855
|
Higashi T et al. |
[Relative Ga-67 image enhancement by iron-loading]. |
1984 |
Kaku Igaku |
pmid:6593479
|
Furuno K et al. |
Influence of dehydration and D-glucarate on distribution and excretion of kanamycin in rats. |
1977 |
Jpn. J. Pharmacol. |
pmid:916384
|
Furuno K et al. |
Effect of D-glucaric acid derivatives on stability of rat liver lysosomes and erythrocytes. |
1974 |
Jpn. J. Pharmacol. |
pmid:4463271
|
Hinohara Y et al. |
Glucuronic acid pathway in alloxan diabetic rabbits. (I). Urinary excretion of metabolites related to the glucuronic acid pathway. |
1974 |
Jpn. J. Pharmacol. |
pmid:4463273
|
Tsuruoka T et al. |
Inhibition of pulmonary metastases and tumor cell invasion in experimental tumors by sodium D-glucaro-delta-lactam (ND2001). |
1995 |
Jpn. J. Cancer Res. |
pmid:7737908
|
Tsuruoka T et al. |
Inhibition of tumor cell haptotaxis by sodium D-glucaro-delta-lactam (ND2001). |
1995 |
Jpn. J. Cancer Res. |
pmid:8567400
|
Adhikary L and Acharya S |
Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. |
2011 Jul-Sep |
JNMA J Nepal Med Assoc |
pmid:22922860
|
Smith TG et al. |
Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. |
2009 |
JAMA |
pmid:19809026
|
Lynn S and McDaniel J |
Managing severe anemia when the patient is a Jehovah's Witness. |
2013 |
JAAPA |
pmid:23610833
|
Gorder V et al. |
Treatment of restless legs syndrome with iron infusion therapy. |
2009 |
JAAPA |
pmid:19354112
|
Yamamoto S et al. |
Iatrogenic osteomalacia: report of two cases. |
2013 |
J. UOEH |
pmid:23475021
|
Wang Y et al. |
Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components. |
2014 |
J. Sci. Food Agric. |
pmid:23716136
|
Kaltwasser JP et al. |
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. |
2001 |
J. Rheumatol. |
pmid:11708414
|
Kolodziejczyk J et al. |
In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components. |
2011 |
J. Physiol. Biochem. |
pmid:21086198
|
Tutor-Crespo MJ et al. |
Effect of antiepileptic drugs on the urinary excretion of porphyrins in non-porphyric subjects. |
2005 |
J. Pharmacol. Sci. |
pmid:16314692
|
Bologa M et al. |
Pregnancy-induced changes in drug metabolism in epileptic women. |
1991 |
J. Pharmacol. Exp. Ther. |
pmid:2033516
|
Patel IH et al. |
Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys. |
1981 |
J. Pharmacol. Exp. Ther. |
pmid:7229992
|
Tanaka E et al. |
Studies on the trimethadione metabolism as a tool for the assessment of drug-metabolizing capacity using plasma and urine of rats pretreated with phenobarbital and 3-methylcholanthrene. |
1982 |
J. Pharmacobio-dyn. |
pmid:7097483
|
Garnham JC et al. |
The effect of repeated administration of diftalone on enzyme induction. |
1978 |
J. Pharm. Pharmacol. |
pmid:27604
|
Oleson L and Court MH |
Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. |
2008 |
J. Pharm. Pharmacol. |
pmid:18718121
|
Latham AN |
D-Glucaric acid as an index of hepatic enzyme induction by anticonvulsant drugs in man. |
1974 |
J. Pharm. Pharmacol. |
pmid:4151390
|
Latham AN |
Effect of in vitro changes in urinary pH on the enzymatic measurement and daily variation in excretion of D-glucaric acid. |
1975 |
J. Pharm. Pharmacol. |
pmid:239180
|